RxDoctor Payments Data

Philip Merritt, MD

Adult Reconstructive Orthopaedic Surgery · Glendale, CANPI 1083696074

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $399,118 of the $449,674 with a category attached, or 88.8%. Zimmer Biomet accounts for 68.0% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $160,552 and has fallen 95.7% since, to $6,939 in 2025.

$449,674in general payments, 2019–2025

Across 86 payments — averaging $5228.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$306K
  • Encore Medical, LP$110K
  • Applied Medical Corporation$26K
  • UOC USA Inc$7K
  • Stryker$317
  • Engage Uni, LLC$114
  • plus $347 from 13 others
$35,316in ownership & investment interests, 2019–2025

Across 7 payments — averaging $5045.14 each. An ownership or investment interest held by the physician or an immediate family member.

  • Applied Medical Corporation$35K

What the payments were for

  • Royalty or licence$399,11889%
  • Consulting fees$24,6455%
  • Travel & lodging$13,2333%
  • Food & beverage$1,9240%
  • Gifts$1140%
  • Ownership interest$10,6402%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$449,674 in reported general payments places this provider in the 85th percentile of 136 adult reconstructive orthopaedic surgery providers in California.

See all adult reconstructive orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$605,146
Medicare patients
899
Services billed
2,198

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib995$29,669
Diclofenac Sodium35$15,919
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen145$970
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim118$243
Doxycycline Hyclate20$179
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$93
Ezetimibe13$77
Methylprednisolone15$69
Gabapentin12$63
Amoxicillin25$58
Meloxicam11$46
Tramadol Hcl26$40

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Glendale

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →